These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 34119171)
21. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4. Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482 [TBL] [Abstract][Full Text] [Related]
22. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. Varshochian R; Riazi-Esfahani M; Jeddi-Tehrani M; Mahmoudi AR; Aghazadeh S; Mahbod M; Movassat M; Atyabi F; Sabzevari A; Dinarvand R J Biomed Mater Res A; 2015 Oct; 103(10):3148-56. PubMed ID: 25773970 [TBL] [Abstract][Full Text] [Related]
23. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
24. Chitosan coated PLGA nanoparticles amplify the ocular hypotensive effect of forskolin: Statistical design, characterization and in vivo studies. Khan N; Ameeduzzafar ; Khanna K; Bhatnagar A; Ahmad FJ; Ali A Int J Biol Macromol; 2018 Sep; 116():648-663. PubMed ID: 29723623 [TBL] [Abstract][Full Text] [Related]
25. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850 [TBL] [Abstract][Full Text] [Related]
27. Neuroprotective effect of insulin-loaded chitosan nanoparticles/PLGA-PEG-PLGA hydrogel on diabetic retinopathy in rats. Rong X; Ji Y; Zhu X; Yang J; Qian D; Mo X; Lu Y Int J Nanomedicine; 2019; 14():45-55. PubMed ID: 30587984 [TBL] [Abstract][Full Text] [Related]
28. Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis. Luo L; Yang J; Oh Y; Hartsock MJ; Xia S; Kim YC; Ding Z; Meng T; Eberhart CG; Ensign LM; Thorne JE; Stark WJ; Duh EJ; Xu Q; Hanes J J Control Release; 2019 Feb; 296():68-80. PubMed ID: 30660629 [TBL] [Abstract][Full Text] [Related]
29. Anti-Angiogenic Activity Of Bevacizumab-Bearing Dexamethasone-Loaded PLGA Nanoparticles For Potential Intravitreal Applications. Liu J; Zhang X; Li G; Xu F; Li S; Teng L; Li Y; Sun F Int J Nanomedicine; 2019; 14():8819-8834. PubMed ID: 31819410 [TBL] [Abstract][Full Text] [Related]
30. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation. Mohammadpour F; Hadizadeh F; Tafaghodi M; Sadri K; Mohammadpour AH; Kalani MR; Gholami L; Mahmoudi A; Chamani J Int J Pharm; 2019 Dec; 572():118710. PubMed ID: 31629731 [TBL] [Abstract][Full Text] [Related]
31. Effect of PEG and water-soluble chitosan coating on moxifloxacin-loaded PLGA long-circulating nanoparticles. Mustafa S; Devi VK; Pai RS Drug Deliv Transl Res; 2017 Feb; 7(1):27-36. PubMed ID: 27576453 [TBL] [Abstract][Full Text] [Related]
32. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303 [TBL] [Abstract][Full Text] [Related]
33. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular. Li J; Tan G; Cheng B; Liu D; Pan W Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370 [TBL] [Abstract][Full Text] [Related]
34. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil. Mohammed M; Mansell H; Shoker A; Wasan KM; Wasan EK Drug Dev Ind Pharm; 2019 Jan; 45(1):76-87. PubMed ID: 30169982 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice. Kefayat A; Vaezifar S Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043 [TBL] [Abstract][Full Text] [Related]
36. Enhancement of oral bioavailability of salmon calcitonin through chitosan-modified, dual drug-loaded nanoparticles. Liu L; Yang H; Lou Y; Wu JY; Miao J; Lu XY; Gao JQ Int J Pharm; 2019 Feb; 557():170-177. PubMed ID: 30597264 [TBL] [Abstract][Full Text] [Related]
38. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP; Jain K; Jain NK Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363 [TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration. Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882 [TBL] [Abstract][Full Text] [Related]
40. Ocular implant containing bevacizumab-loaded chitosan nanoparticles intended for choroidal neovascularization treatment. Badiee P; Varshochian R; Rafiee-Tehrani M; Abedin Dorkoosh F; Khoshayand MR; Dinarvand R J Biomed Mater Res A; 2018 Aug; 106(8):2261-2271. PubMed ID: 29637733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]